Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
FUSION PROTEIN OF PLANT-PRODUCED EPO AND TRANSFERRIN AND APPLICATION THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/259109
Kind Code:
A1
Abstract:
Provided by the present invention is a fusion protein of plant-produced oral EPO and transferrin, using a plant such as lettuce as an expression platform for recombinant protein production. Further provided is an application of the fusion protein to the manufacture of oral capsules. Biological activity test results show that an anemia treatment capsule produced by the platform technique significantly increases the number of red blood cells in mice.

Inventors:
WANG YUEJU (CN)
Application Number:
PCT/CN2020/089980
Publication Date:
December 30, 2020
Filing Date:
May 13, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
WANG YUEJU (CN)
International Classes:
C07K19/00; A01H5/00; A61K38/18; A61K47/64; A61P7/06; C12N15/62; C12N15/82
Domestic Patent References:
WO2005021579A22005-03-10
Foreign References:
CN110229237A2019-09-13
CN102936288A2013-02-20
CN107188970A2017-09-22
Other References:
DATABASE Protein 27 December 2020 (2020-12-27), ANONYMOUS: "erythropoietin precursor [Homo sapiens]", XP055771535, retrieved from NCBI
CHEN, KAI: "The Transgenic Plants Express Foreign Medical Protein", JOURNAL OF HANDAN AGRICULTURAL COLLEGE, UNITED STATES, vol. 21, no. 1, 7 January 2005 (2005-01-07), United States, XP055771533
Attorney, Agent or Firm:
UNITALEN ATTORNEYS AT LAW (CN)
Download PDF: